Signet Ring Cell Adenocarcinoma — Trials

Signet Ring Cell Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

30 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (10)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02235324	Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer	withdrawn	Phase 2	0	University of Southern CaliforniaOTHER	1	May 6, 2015	clinicaltrials
NCT01403103	Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer	withdrawn	Early Phase 1	0	Case Comprehensive Cancer CenterOTHER	0	Jan 17, 2014	clinicaltrials